相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis
Benedikt Schoser et al.
JOURNAL OF NEUROLOGY (2017)
The emerging phenotype of late-onset Pompe disease: A systematic literature review
Justin Chan et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Long-term benefit of enzyme replacement therapy in Pompe disease A 5-year prospective study
Esther Kuperus et al.
NEUROLOGY (2017)
Cessation and resuming of alglucosidase alfa in Pompe disease: a retrospective analysis
Thomas Hundsberger et al.
JOURNAL OF NEUROLOGY (2014)
Swiss national guideline for reimbursement of enzyme replacement therapy in late-onset Pompe disease
Thomas Hundsberger et al.
JOURNAL OF NEUROLOGY (2013)
Low-frequency enzyme replacement therapy in late-onset pompe disease
Dar-Shong Lin et al.
MUSCLE & NERVE (2013)
Autophagy and mitochondria in Pompe disease: Nothing is so new as what has long been forgotten
Nina Raben et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2012)
36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy
Caroline Regnery et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years
C. Angelini et al.
JOURNAL OF NEUROLOGY (2012)
Effect of enzyme therapy and prognostic factors in 69 adults with Pompe disease: an open-label single-center study
Juna M. de Vries et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II
Bruno Bembi et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial
S. Strothotte et al.
JOURNAL OF NEUROLOGY (2010)
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
Ans T. van der Ploeg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Early Treatment With Alglucosidase Alfa Prolongs Long-Term Survival of Infants With Pompe Disease
Priya S. Kishnani et al.
PEDIATRIC RESEARCH (2009)
Protocol for the locomotor experience applied post-stroke (LEAPS) trial: a randomized controlled trial
Pamela W. Duncan et al.
BMC NEUROLOGY (2007)
Recombinant human acid α-glucosidase -: Major clinical benefits in infantile-onset Pompe disease
P. S. Kishnani et al.
NEUROLOGY (2007)
Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies
ISJ Merkies et al.
MUSCLE & NERVE (2002)
分享论文
